Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cv Sciences Inc (CVSI)

Cv Sciences Inc (CVSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,115
  • Shares Outstanding, K 184,794
  • Annual Sales, $ 16,000 K
  • Annual Income, $ 3,100 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.59
  • Price/Sales 0.51
  • Price/Cash Flow 2.11
  • Price/Book 3.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $0.00 on 11/14/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0311 +23.79%
on 11/14/24
0.0496 -22.38%
on 10/25/24
-0.0065 (-14.44%)
since 10/22/24
3-Month
0.0311 +23.79%
on 11/14/24
0.0526 -26.81%
on 08/27/24
-0.0119 (-23.61%)
since 08/22/24
52-Week
0.0301 +27.91%
on 03/06/24
0.1015 -62.07%
on 06/05/24
+0.0058 (+17.74%)
since 11/22/23

Most Recent Stories

More News
CV Sciences, Inc. Launches Reserve Sleep Gummies

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV Sciences, Inc. Reports First Quarter 2023 Financial Results

/PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

CVSI : 0.0385 (-13.48%)
CV Sciences, Inc. Introduces New THC Offering

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...

CVSI : 0.0385 (-13.48%)
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

/PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent supplier and manufacturer of hemp cannabidiol...

CVSI : 0.0385 (-13.48%)
CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

/PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...

CVSI : 0.0385 (-13.48%)

Business Summary

CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product...

See More

Key Turning Points

3rd Resistance Point 0.0569
2nd Resistance Point 0.0514
1st Resistance Point 0.0450
Last Price 0.0385
1st Support Level 0.0331
2nd Support Level 0.0276
3rd Support Level 0.0212

See More

52-Week High 0.1015
Fibonacci 61.8% 0.0742
Fibonacci 50% 0.0658
Fibonacci 38.2% 0.0574
Last Price 0.0385
52-Week Low 0.0301

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar